
#504 - Bill Taranto, President at Merck Global Health Innovation Fund
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to basket failed.
Please try again later
Add to wishlist failed.
Please try again later
Remove from wishlist failed.
Please try again later
Adding to library failed
Please try again
Follow podcast failed
Unfollow podcast failed
-
Narrated by:
-
By:
About this listen
Join us on the latest episode, hosted by Jared S. Taylor!
Our Guest: Bill Taranto, President at Merck Global Health Innovation Fund.
What you’ll get out of this episode:
- Bill Taranto’s Journey: From Johnson & Johnson to leading Merck’s $600M GHI Fund focused on digital health and technology.
- Four Core Investment Areas: Drug discovery, clinical development, supply chain, and patient access/data.
- Portfolio Spotlights: Companies like Npower, Unnatural Products, Aerosafe Global, Cure AI, and Prognos are driving impactful innovation.
- Strategic Value of CVCs: Beyond capital, CVCs offer startups technical expertise, commercial agreements, and long-term support.
- Navigating Market Challenges: Insights on VC pullback, consolidation trends, and advice for startups on sustainable growth.
To learn more about Merck:
Website https://www.merck.com/
Linkedin https://www.linkedin.com/company/merck/
Our sponsors for this episode are:
Sage Growth Partners https://www.sage-growth.com/
Quantum Health https://www.quantum-health.com/
Show and Host's Socials:
Slice of Healthcare
LinkedIn: https://www.linkedin.com/company/sliceofhealthcare/
Jared S Taylor
LinkedIn: https://www.linkedin.com/in/jaredstaylor/
WHAT IS SLICE OF HEALTHCARE?
The go-to site for digital health executive/provider interviews, technology updates, and industry news. Listed to in 65+ countries.
No reviews yet